Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hope Wei

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Life Sciences|November 4, 2023
Stem cell heterogeneity, plasticity, and regulationZiyang Cui, Hope Wei, Colin Goding, et al.
Nature Communications|May 21, 2020
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilitiesCaitlin A Nichols, William J Gibson, Meredith S Brown, et al.
Nature Medicine|April 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trialOmar Nadeem, David M Cordas Dos Santos, Sarah Nikiforow, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Life Sciences|November 4, 2023
Stem cell heterogeneity, plasticity, and regulationZiyang Cui, Hope Wei, Colin Goding, et al.
Nature Communications|May 21, 2020
Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilitiesCaitlin A Nichols, William J Gibson, Meredith S Brown, et al.
Nature Medicine|April 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trialOmar Nadeem, David M Cordas Dos Santos, Sarah Nikiforow, et al.
Pageof 1